|
1
|
Thalmann S and Meier CA: Local adipose
tissue depots as cardiovascular risk factors. Cardiovasc Res.
75:690–701. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Molica F, Morel S, Kwak BR,
Rohner-Jeanrenaud F and Steffens S: Adipokines at the crossroad
between obesity and cardiovascular disease. Thromb Haemost.
113:553–566. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li FY, Cheng KK, Lam KS, Vanhoutte PM and
Xu A: Cross-talk between adipose tissue and vasculature: Role of
adiponectin. Acta Physiol (Oxf). 203:167–180. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cai X, Li X, Li L, Huang XZ, Liu YS, Chen
L, Zhang K, Wang L, Li X, Song J, et al: Adiponectin reduces
carotid atherosclerotic plaque formation in ApoE−/−mice: Roles of
oxidative and nitrosative stress and inducible nitric oxide
synthase. Mol Med Rep. 11:1715–1721. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Withers SB, Bussey CE, Saxton SN, Melrose
HM, Watkins AE and Heagerty AM: Mechanisms of
adiponectin-associated perivascular function in vascular disease.
Arterioscler Thromb Vasc Biol. 34:1637–1642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu Y, Palanivel R, Rai E, Park M, Gabor
TV, Scheid MP, Xu A and Sweeney G: Adiponectin stimulates autophagy
and reduces oxidative stress to enhance insulin sensitivity during
high-fat diet feeding in mice. Diabetes. 64:36–48. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li C, Wang Z, Wang C, Ma Q and Zhao Y:
Perivascular adipose tissue-derived adiponectin inhibits
collar-induced carotid atherosclerosis by promoting macrophage
autophagy. PLoS One. 10:e01240312015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qi GM, Jia LX, Li YL, Li HH and Du J:
Adiponectin suppresses angiotensin II-induced inflammation and
cardiac fibrosis through activation of macrophage autophagy.
Endocrinology. 155:2254–2265. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yamauchi T, Kamon J, Ito Y, Tsuchida A,
Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, et
al: Cloning of adiponectin receptors that mediate antidiabetic
metabolic effects. Nature. 423:762–769. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang ZV and Scherer PE: Adiponectin, the
past two decades. J Mol Cell Biol. 8:93–100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhan JK, Wang YJ, Wang Y, Tang ZY, Tan P,
Huang W and Liu YS: Adiponectin attenuates the osteoblastic
differentiation of vascular smooth muscle cells through the
AMPK/mTOR pathway. Exp Cell Res. 323:352–358. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang W, Shu C, Li Q, Li M and Li X:
Adiponectin affects vascular smooth muscle cell proliferation and
apoptosis through modulation of the mitofusin-2-mediated
Ras-Raf-Erk1/2 signaling pathway. Mol Med Rep. 12:4703–4707. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Alexis JD, Wang N, Che W, Lerner-Marmarosh
N, Sahni A, Korshunov VA, Zou Y, Ding B, Yan C, Berk BC and Abe J:
Bcr kinase activation by angiotensin II inhibits
peroxisome-proliferator-activated receptor gamma transcriptional
activity in vascular smooth muscle cells. Circ Res. 104:69–78.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang Z, Hong LK, Follett J, Wabitsch M,
Hamilton NA, Collins BM, Bugarcic A and Teasdale RD: Functional
characterization of retromer in GLUT4 storage vesicle formation and
adipocyte differentiation. Faseb J. 30:1037–1050. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao Y, Zhang C, Wei X, Li P, Cui Y, Qin
Y, Wei X, Jin M, Kohama K and Gao Y: Heat shock protein 60
stimulates the migration of vascular smooth muscle cells via
Toll-like receptor 4 and ERK MAPK activation. Sci Rep. 5:153522015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Montezano AC, Cat Nguyen Dinh A, Rios FJ
and Touyz RM: Angiotensin II and vascular injury. Curr Hypertens
Rep. 16:4312014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu L, Huang X, Huang K, Gui C, Huang Q and
Wei B: Ligustrazine attenuates the platelet-derived growth
factor-BB-induced proliferation and migration of vascular smooth
muscle cells by interrupting extracellular signal-regulated kinase
and P38 mitogen-activated protein kinase pathways. Mol Med Rep.
12:705–711. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Okada-Iwabu M, Yamauchi T, Iwabu M, Honma
T, Hamagami K, Matsuda K, Yamaguchi M, Tanabe H, Kimura-Someya T,
Shirouzu M, et al: A small-molecule AdipoR agonist for type 2
diabetes and short life in obesity. Nature. 503:493–499. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fisman EZ and Tenenbaum A: Adiponectin: A
manifold therapeutic target for metabolic syndrome, diabetes and
coronary disease? Cardiovasc Diabetol. 13:1032014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takaoka M, Nagata D, Kihara S, Shimomura
I, Kimura Y, Tabata Y, Saito Y, Nagai R and Sata M: Periadventitial
adipose tissue plays a critical role in vascular remodeling. Circ
Res. 105:906–911. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sheng LJ, Ruan CC, Ma Y, Chen DR, Kong LR,
Zhu DL and Gao PJ: Beta3 adrenergic receptor is involved in
vascular injury in deoxycorticosterone acetate-salt hypertensive
mice. FEBS lett. 590:769–778. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Takaoka M, Suzuki H, Shioda S, Sekikawa K,
Saito Y, Nagai R and Sata M: Endovascular injury induces rapid
phenotypic changes in perivascular adipose tissue. Arterioscler
Thromb Vasc Biol. 30:1576–1582. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Scherer PE, Williams S, Fogliano M,
Baldini G and Lodish HF: A novel serum protein similar to C1q,
produced exclusively in adipocytes. J Biol Chem. 270:26746–26749.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee S and Kwak HB: Role of adiponectin in
metabolic and cardiovascular disease. J Exerc Rehabil. 10:54–59.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chakraborti CK: Role of adiponectin and
some other factors linking type 2 diabetes mellitus and obesity.
World J Diabetes. 6:1296–1308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lima Freitas LC, Braga VA, do Socorro de
Franca Silva M, Cruz JC, Sousa Santos SH, de Oliveira Monteiro MM
and Balarini CM: Adipokines, diabetes and atherosclerosis: An
inflammatory association. Front Physiol. 6:3042015.PubMed/NCBI
|
|
27
|
Ndisang JF and Jadhav A: Heme arginate
therapy enhanced adiponectin and atrial natriuretic peptide, but
abated endothelin-1 with attenuation of kidney histopathological
lesions in mineralocorticoid-induced hypertension. J Pharmacol Exp
Ther. 334:87–98. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang F, Ren X, Zhao M, Zhou B and Han Y:
Angiotensin-(1–7) abrogates angiotensin II-induced proliferation,
migration and inflammation in VSMCs through inactivation of
ROS-mediated PI3 K/Akt and MAPK/ERK signaling pathways. Sci Rep.
6:346212016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kadowaki T and Yamauchi T: Adiponectin and
adiponectin receptors. Endocr Rev. 26:439–451. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamauchi T and Kadowaki T: Adiponectin
receptor as a key player in healthy longevity and obesity-related
diseases. Cell Metab. 17:185–196. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lustig Y, Hemi R and Kanety H: Regulation
and function of adiponectin receptors in skeletal muscle. Vitam
Horm. 90:95–123. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wade TE, Mathur A, Lu D, Swartz-Basile DA,
Pitt HA and Zyromski NJ: Adiponectin receptor-1 expression is
decreased in the pancreas of obese mice. J Surg Res. 154:78–84.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin T, Qiu Y, Liu Y, Mohan R, Li Q and Lei
B: Expression of adiponectin and its receptors in type 1 diabetes
mellitus in human and mouse retinas. Mol Vis. 19:1769–1778.
2013.PubMed/NCBI
|
|
34
|
Yu Y, Bao BJ, Fan YP, Shi L and Li SQ:
Changes of adiponectin and its receptors in rats following chronic
renal failure. Ren Fail. 36:92–97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Thundyil J, Pavlovski D, Sobey CG and
Arumugam TV: Adiponectin receptor signalling in the brain. Br J
Pharmacol. 165:313–327. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Almabrouk TA, Ewart MA, Salt IP and
Kennedy S: Perivascular fat, AMP-activated protein kinase and
vascular diseases. Br J Pharmacol. 171:595–617. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yan J, Gan L, Qi R and Sun C: Adiponectin
decreases lipids deposition by p38 MAPK/ATF2 signaling pathway in
muscle of broilers. Mol Biol Rep. 40:7017–7025. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Y, Zhang J, Zhang L, Gao P and Wu X:
Adiponectin attenuates high glucose-induced apoptosis through the
AMPK/p38 MAPK signaling pathway in NRK-52E cells. PLoS One.
12:e01782152017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pu Y, Wang M, Hong Y, Wu Y and Tang Z:
Adiponectin promotes human jaw bone marrow mesenchymal stem cell
chemotaxis via CXCL1 and CXCL8. J Cell Mol Med. 21:1411–1419. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang CY, Chang AC, Chen HT, Wang SW, Lo
YS and Tang CH: Adiponectin promotes VEGF-C-dependent
lymphangiogenesis by inhibiting miR-27b through a CaMKII/AMPK/p38
signaling pathway in human chondrosarcoma cells. Clin Sci (Lond).
130:1523–1533. 2016. View Article : Google Scholar : PubMed/NCBI
|
